文献速递肿瘤 PET/CT核素与放射性配体治疗

18F-PSMA PET/MRI在前列腺癌根治术后复发中的作用

Role of 18F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy.
PubMed 文献 · J Nucl Med · 2026-09-02

该研究评估了18F-PSMA PET/MRI一站式方案(单次注射后行盆腔PET/mpMRI和全身PET/CT)在前列腺癌根治术后生化复发检测中的价值。106例连续患者中,PET/MRI检测到52例(49.06%)局部复发,多于PET/CT的42例(39.62%)和mpMRI的46例(43.00%)。mpMRI和PSMA PET的灵敏度分别为88.5%和78.8%,特异度分别为100%和98.1%。

要点

  • 18F-PSMA PET/MRI一站式方案可同时行盆腔PET/mpMRI和全身PET/CT。
  • PET/MRI检测局部复发(49.06%)多于PET/CT(39.62%)和mpMRI(43.00%)。
  • mpMRI与PSMA PET灵敏度分别为88.5%和78.8%,特异度分别为100%和98.1%。

核心结论

  • 18F-PSMA PET/MRI在前列腺癌局部复发检测中优于PET/CT和mpMRI。

研究设计与样本

  • 研究纳入106例前列腺癌根治术后生化复发患者,采用单次注射18F-PSMA后行盆腔PET/mpMRI和全身PET/CT的一站式方案。
  • 每种影像模态由2名独立且有经验的读者盲法审阅,以MRI或PSMA PET任一阳性作为参考标准。

主要发现

  • 18F-PSMA PET/MRI检测到52例(49.06%)局部复发,18F-PSMA PET/CT检测到42例(39.62%),mpMRI检测到46例(43.00%)。
  • 不一致病例18例(17%),其中10%仅MRI阳性,7%仅PSMA PET阳性。
  • 与18F-PSMA PET/MRI相比,mpMRI灵敏度88.5%、特异度100%,PSMA PET灵敏度78.8%、特异度98.1%。

临床怎么用

  • 对于前列腺癌根治术后生化复发患者,可考虑采用18F-PSMA PET/MRI一站式方案评估局部复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

18F-PSMA PET/CT and pelvic MRI are useful for assessing biochemical recurrence of prostate cancer after prostatectomy. We evaluated the role of 18F-PSMA PET/MRI in a 1-stop-shop protocol combining a single injection of 18F-PSMA, followed by pelvic PET/multiparametric MRI (mpMRI) and whole-body PET/CT acquisitions for the detection of recurrent disease. Methods: We evaluated 106 consecutive patients referred to our institute for biochemical recurrence after prostatectomy using a 1-stop-shop protocol comprising whole-body 18F-PSMA PET/CT and pelvic 18F-PSMA PET/mpMRI. Each imaging modality was reviewed in a blinded manner by 2 independent, experienced readers. 18F-PSMA PET/MRI, with positivity on either MRI or PSMA PET, served as the reference standard. Results: 18F-PSMA PET/MRI detected more local recurrences (n = 52, 49.06%) compared with 18F-PSMA PET/CT (n = 42, 39.62%) and mpMRI (n = 46, 43.00%). Discordant cases accounted for 18 patients (17%): 10% were positive only on MRI and 7% only on PSMA PET. Compared with 18F-PSMA PET/MRI, both mpMRI and 18F-PSMA PET demonstrated similar performance, with sensitivities of 88.5% and 78.8% and specificities of 100% and 98.1%, respectively. Conclusion: 18F-PSMA PET/MRI outperformed PET/CT and mpMRI in the detection of local recurrences of prostate cancer.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Paule A, Masson S, Rose Dite Modestine J, et al. Role of 18F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy. J Nucl Med. 2026. PMID: 42242874. doi:10.2967/jnumed.126.272126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。